Our team is here to achieve your goals! Speak with our experts.
Start Live Chat
Schedule Online Consultation
Request a Demo
At-Line Monitoring in Biopharma: Challenges and Fixes
mins
19 May, 2026
Tatjana Strom
Real progress means mastering the human moments which automation cannot replace.
From Molecule to Manufacture: The Role of Lab-Based Analytics
Even in a world of automation and in-line control, at-line analytics remain essential. From monoclonal antibodies to mRNA therapeutics, cell and gene therapies, and peptides, scientists depend on them to ensure reproducibility, minimize human influence, and maintain traceability under GMP conditions.
Reliable at-line solutions control what automation cannot: variability, delay, and data loss. This article highlights how scientists can strengthen process confidence from development labs to GMP production—despite human risk.
"Mettler-Toledo’s solutions provide critical, real-time at-line analytics that enhance biopharma process control, quality, and speed to market."
Dr. Hans-Joachim Muhr, Segment Business Development Manager
Even as real-time analytics and automation advance, most critical quality attributes still rely on at-line measurements — and that won’t change overnight. Biological variability, evolving regulatory frameworks, and sensor limitations make full in-line coverage unrealistic for many workflows. The opportunity now lies in improving how at-line is done: faster transfer, smarter data integration, and more robust method design.
When carefully selected and connected, instruments can turn these manual checkpoints into seamless data streams, reducing the friction, human error, and delays that have long defined at-line work.
Ensuring Quality Across Processes and Modalities
At-line analytics strengthens process robustness across every stage of biologics manufacturing. From early development to scale-up, they deliver precise, consistent results where critical data must be verified close to the process.
Multi-parametric at-line assays monitor nutrient consumption and metabolite accumulation in real time. They support faster process optimization and consistent productivity across development cycles.
Assay development
At-line pH,conductivity, osmolality, and viability testing provide immediate feedback during method refinement. These parameters ensure data consistency and faster transfer from lab to GMP production.
Across modalities — from mAbs and mRNA platforms to CGTs and peptides — these applications illustrate the continued importance of at-line analytics throughout biopharmaceutical development and manufacturing. Despite advances in automation, many critical quality attributes still rely on manual sampling and at-line verification.
Today’s latest at-line solutions are increasingly integrated and connected, reducing the human factor, enhancing data reliability, and strengthening overall process robustness — enabling confident decisions and consistent quality across every biopharmaceutical workflow.
Advanced biologics differ widely in production scale — from large continuous runs to small patient-specific batches. Yet in every setup, traceable and reliable measurements remain key to ensuring consistent quality.
In large-scale biologics production
At-line analytics secure process traceability and control from seed train to formulation, maintaining robustness and compliance across production stages.
In small-batch precision manufacturing
They deliver fast, traceable results directly at the bench, reducing variability and enabling confident decisions without dependence on fixed instrumentation setups.
Why At-Line Tools Remain Indispensable
Despite strong momentum toward real-time analytics and digitalization, many critical biopharma assays still rely on lab-based or at-line tools, and for very practical reason:
Real-Time Quality Control
Enables real-time process adjustments, ensuring product quality and compliance with regulatory standards like FDA and EMA guidelines. This is crucial for maintaining consistent drug efficacy and patient safety.
Process Optimization
At-line monitoring provides immediate feedback on critical quality attributes (CQAs) and critical process parameters (CPPs), allowing for more efficient upstream and downstream processing.
Reduced Batch Failures
By identifying issues early, it reduces the risk of costly batch failures and the need for extensive rework.
Regulatory Compliance and PAT
It supports Process Analytical Technology (PAT) frameworks, which are increasingly encouraged by regulators to enhance manufacturing efficiency and control.
Cost Efficiency
It helps minimize waste and reduce production costs by quickly detecting deviations from the ideal process.
Scalability and Continuous Manufacturing
It is essential for the transition to continuous manufacturing, which requires constant quality checks.
In practice, many organizations adopt a hybrid approach, using a combination of inline, at-line, and offline tools depending on the specific process, molecule, and compliance requirements. This flexible strategy allows teams to balance automation with scientific insight, supporting data-driven decisions across development and manufacturing, even as technologies and regulatory expectations continue to evolve.
Conclusion: Precision Meets Practicality
At-line monitoring remains a foundation of modern biopharma. It places lab-based insights next to the process, validates in-line performance, and ensures regulatory compliance without slowing innovation.
Accuracy
When in-line sensors drift, at-line tools verify and confirm measurement accuracy.
Insight
As complexity increases, at-line methods provide the real-world data scientists need to make confident decisions.
Fast Data Generation
With tight timelines, at-line testing delivers actionable results long before full validation cycles are complete.
A Partner for Progress
At METTLER TOLEDO, we have seen this transformation unfold across hundreds of customer collaborations — from early development through commercial manufacturing. Biopharmaceutical and pharmaceutical industries are facing urgent efficiency demands, and we are committed to supporting them with scalable, precise, and future-ready solutions. Whether it is enabling real-time solvent monitoring, automated reagent dosing, or inline analytics in GMP manufacturing, our goal is the same: to help teams build a strong, scalable foundation.
